Collagen supplements are generally safe for people with high blood pressure, and the available research suggests they may even produce a modest blood-pressure-lowering effect. A meta-analysis of placebo-controlled trials found that collagen peptide supplementation reduced systolic blood pressure by roughly 5 mmHg on average. That said, the research is still limited, and collagen supplements aren’t regulated like medications, which introduces quality and contamination questions worth understanding before you add them to your routine.
How Collagen Peptides Can Lower Blood Pressure
When your body digests collagen, it breaks the protein down into smaller chains called peptides. Some of these peptides happen to inhibit an enzyme called ACE (angiotensin-converting enzyme), which is the same enzyme targeted by a widely prescribed class of blood pressure drugs. Lab studies have identified specific peptide sequences from bovine collagen that block ACE activity and can cross the intestinal wall while retaining that activity, meaning they could plausibly work after you swallow them, not just in a test tube.1Food Research International. Angiotensin I–converting enzyme–inhibitory peptides from bovine collagen: insights into inhibitory mechanism and transepithelial transport Similar ACE-blocking tripeptides have been found in collagen broken down with ginger protease, with some showing strong inhibition at low concentrations.2PubMed. Characterization of Angiotensin-Converting Enzyme Inhibitory Activity of X-Hyp-Gly-Type Tripeptides: Importance of Collagen-Specific Prolyl Hydroxylation
The downstream effect of blocking ACE goes beyond just preventing blood vessels from constricting. ACE normally degrades a molecule called bradykinin, which signals blood vessel walls to release nitric oxide, a compound that relaxes arteries. By slowing the breakdown of bradykinin, collagen peptides may help keep arteries more relaxed and flexible, reducing the resistance your heart has to pump against.3Nutrition Research Reviews. Collagen supplementation in metabolic syndrome: a narrative review unraveling the biological mechanisms and effects This is essentially the same mechanism by which ACE-inhibitor medications lower blood pressure, though the effect from a dietary supplement is far weaker than a pharmaceutical dose.
What the Clinical Evidence Actually Shows
The most comprehensive look at collagen’s cardiovascular effects comes from a systematic review and meta-analysis of randomized, placebo-controlled trials. Pooling data across studies, collagen peptide supplementation reduced systolic blood pressure by about 5 mmHg. The review also found modest improvements in body composition and a small decrease in LDL cholesterol.4PubMed. Effects of collagen peptide supplementation on cardiovascular markers: a systematic review and meta-analysis of randomised, placebo-controlled trials A 5-point drop in systolic pressure is meaningful in population terms (at scale, that reduction is associated with meaningfully fewer strokes and heart attacks), but for an individual already on medication, it’s a subtle addition, not a replacement for treatment.
A broader meta-analysis looking at blood-pressure effects of all food-protein-derived peptides (not just collagen) found an average reduction of about 3 mmHg for systolic pressure and roughly 2 mmHg for diastolic pressure across trials.5PubMed Central. The Blood-Pressure-Lowering Effect of Food-Protein-Derived Peptides: A Meta-Analysis of Recent Clinical Trials So collagen’s effect appears to be in the same general ballpark as peptides from other dietary proteins like casein and fish. None of these effects are dramatic, but they consistently point in the same direction: a small, favorable nudge downward.
One clinical trial focused specifically on people with both type 2 diabetes and primary hypertension. Patients who took marine collagen peptides twice daily for three months while continuing their regular blood pressure and diabetes medications saw reductions in diastolic blood pressure and mean arterial pressure compared to controls. Kidney function markers also improved.6The American Journal of the Medical Sciences. Therapeutic Effects of Marine Collagen Peptides on Chinese Patients With Type 2 Diabetes Mellitus and Primary Hypertension This study is particularly relevant because the participants were already on medications for both conditions, and the collagen was added on top of their standard treatment without apparent adverse effects. It’s a single trial, so it can’t settle the question, but it’s reassuring for the safety concern specifically.
The ACE-Inhibitor Medication Question
If collagen peptides inhibit ACE through a mechanism similar to prescription ACE inhibitors, it’s natural to wonder whether combining the two could cause blood pressure to drop too low. In practice, the potency difference is enormous. Prescription ACE inhibitors are pharmaceutical-grade molecules dosed to produce a reliable, substantial effect. Collagen peptides are food-derived fragments with far weaker binding and far less predictable absorption. The clinical trials showing a 3-5 mmHg reduction are measuring the average effect of the entire supplement, not the concentrated punch of a single active ingredient.
The marine collagen trial mentioned above specifically enrolled patients who were already taking blood pressure medications (along with diabetes drugs), and the researchers measured blood pressure throughout the three-month study. No reports of hypotension or dangerously low readings emerged.6The American Journal of the Medical Sciences. Therapeutic Effects of Marine Collagen Peptides on Chinese Patients With Type 2 Diabetes Mellitus and Primary Hypertension That’s reassuring, though it’s worth flagging that if you’re on multiple blood pressure medications and your pressure is already at the low end of your target range, even a small additive effect could matter. If that describes your situation, mentioning collagen to your doctor is a reasonable precaution, though the risk of a clinically dangerous interaction from a standard collagen supplement is low based on current evidence.
Contaminants Worth Knowing About
The bigger practical concern for people with high blood pressure isn’t the collagen itself but what else might be in the supplement. Collagen is sourced from animal tissues (bones, skin, scales, cartilage), and those tissues can accumulate heavy metals. A recent study examining fish and jellyfish collagen supplements found that arsenic was the most commonly detected toxic element, followed by lead. However, none of the tested products exceeded EU safety limits, and the estimated daily intake from normal use fell well below toxicity thresholds.7PubMed Central. Toxic metals and metalloids in collagen supplements of fish and jellyfish origin: Risk assessment for daily intake Jellyfish-derived collagen and certain fish skin extracts in that study showed no detectable toxic metals at all.
Why does this matter for blood pressure specifically? Chronic heavy metal exposure, particularly to lead and cadmium, is an established contributor to hypertension. If you’re already managing high blood pressure, you don’t want your supplement quietly adding to the problem. The evidence so far suggests that reputable collagen products keep heavy metal levels within safe bounds, but the supplement industry is loosely regulated, and quality varies between brands. Third-party testing certifications (USP, NSF, ConsumerLab) remain the most practical way to verify what’s actually in a product.
Sodium and Additives in Flavored Products
Plain collagen peptide powder has negligible sodium. But the moment you move to flavored collagen drinks, collagen-infused broths, or ready-to-mix products, sodium content can climb. Bone broth marketed as a collagen source is a common culprit, sometimes packing several hundred milligrams of sodium per serving. For someone following a sodium-restricted diet to manage blood pressure, that can add up quickly across a day.
The fix is straightforward: read the nutrition label. Unflavored hydrolyzed collagen powder mixed into water, coffee, or a smoothie will contribute essentially no sodium. If you prefer bone broth, compare brands and look for lower-sodium options. The collagen peptides themselves aren’t the sodium problem; it’s the flavoring, seasoning, and processing around them.
Glycine and Broader Metabolic Effects
Collagen is unusually rich in the amino acid glycine, making up roughly a third of its amino acid profile. Glycine has drawn research attention for its effects on metabolic syndrome, a cluster of conditions that includes high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol. A review of available evidence found that glycine supplementation improves several metabolic syndrome components, including hypertension.8PubMed. Effects of glycine on metabolic syndrome components: a review The mechanisms likely involve glycine’s role in forming glutathione (a key antioxidant), reducing inflammation, and improving insulin sensitivity.
This means collagen may offer a two-track benefit for blood pressure: the ACE-inhibiting peptides produced during digestion, and the glycine delivered as a basic amino acid. Neither effect is strong enough to replace medication, but for someone managing hypertension alongside related metabolic issues like prediabetes or high cholesterol, the combined nudge across multiple markers could be genuinely useful as part of a broader dietary strategy.
Does the Source of Collagen Matter
Collagen supplements come from bovine (cow), porcine (pig), marine (fish), and occasionally poultry sources. A randomized crossover study in healthy people found that the source affects how much bioactive peptide you absorb: porcine collagen hydrolysate delivered measurably more total hydroxyproline-containing peptides into the bloodstream than fish collagen, and lower-molecular-weight bovine collagen outperformed higher-molecular-weight bovine collagen.9PubMed Central. Absorption of bioactive peptides following collagen hydrolysate intake: a randomized, double-blind crossover study in healthy individuals These differences in absorption could translate to differences in the strength of any ACE-inhibiting effect, though nobody has directly compared the blood-pressure impact of different collagen sources head to head in a clinical trial.
Marine collagen is the type most often used in blood-pressure-specific research, partly because fish peptides have a long history in ACE-inhibitor research and partly because marine collagen tends to have smaller peptide fragments that are easier to absorb. If your primary interest in collagen is the blood pressure angle rather than, say, joint or skin health, marine collagen hydrolysate is probably the best-studied option. But all sources appear to produce at least some ACE-inhibiting peptide fragments during digestion.
Allergic Reactions and Other Side Effects
Collagen supplements are generally well tolerated, and serious adverse events in clinical trials are rare. The most commonly reported side effects are mild gastrointestinal symptoms: bloating, a feeling of fullness, or an unpleasant aftertaste. These tend to be more common at higher doses and often diminish after a few days of use.
Genuine allergic reactions to collagen exist but are uncommon. Case reports have documented allergic responses to bovine collagen, including swelling around the eyes and throat after consuming gelatin-containing foods.10PubMed Central. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons If you have a known allergy to fish, shellfish, or beef, choose a collagen source from a different animal. People with egg allergies are generally fine with collagen since it’s derived from connective tissue rather than eggs, but cross-contamination during manufacturing is always a possibility with supplements.
Practical Dosing Considerations
Most clinical trials on collagen and cardiovascular markers have used doses in the range of 2.5 to 15 grams per day, with the majority clustering around 5 to 10 grams. Standard commercial collagen supplements typically recommend 10 to 20 grams per day, which falls within or slightly above the range studied. There’s no established upper limit specific to blood pressure effects, but using more doesn’t necessarily mean more benefit, since your gut can only produce so many bioactive peptides from a given serving.
Timing doesn’t appear to matter much. Some people take collagen in the morning with coffee, others before bed. No evidence suggests that the blood-pressure-related effects are sensitive to when you take it. Consistency over weeks to months matters more than timing within the day. In the marine collagen trial with hypertensive patients, the protocol was twice daily for three months before blood pressure changes became statistically clear.6The American Journal of the Medical Sciences. Therapeutic Effects of Marine Collagen Peptides on Chinese Patients With Type 2 Diabetes Mellitus and Primary Hypertension
How Animal Studies Fit Into the Picture
Much of the foundational work on collagen and blood pressure comes from experiments in spontaneously hypertensive rats, a lab model bred to develop high blood pressure. In one study, a low-molecular-weight fraction of chicken collagen hydrolysate produced a sharp blood pressure drop of about 50 mmHg within six hours of a single dose, and longer-term daily dosing suppressed the progressive rise in blood pressure these rats normally experience.11Journal of Agricultural and Food Chemistry. Angiotensin I-converting enzyme-inhibitory peptides obtained from chicken collagen hydrolysate Those numbers sound dramatic, but rat models consistently overestimate the magnitude of effects that translate to humans. What the animal work does confirm is that the mechanism is real: collagen-derived peptides can act on the same biological pathway as ACE-inhibitor drugs, even in a living organism and not just in a petri dish.
The gap between animal data and human trials is where the field currently sits. The human evidence is positive but limited in volume. More placebo-controlled trials focused specifically on people with hypertension, rather than healthy volunteers or mixed populations, would strengthen the case considerably. For now, the trajectory of the evidence is encouraging, and nothing in the existing research raises a red flag about safety in the context of high blood pressure.